Cell lines used in prostate cancer research: a compendium of old and new lines--part 2.

PURPOSE This is part 2 of a 2-part review. Research into the molecular mechanisms underlying the various aspects of prostate cancer (PCa) requires the use of in vivo and in vitro model systems. In the last few years many new cell lines have been established by investigators from primary tissue sources and clonal derivatives of previously established lines. Therefore, the purpose of this 2-part review is to catalogue the current human cell lines developed for PCa research, as reported in the literature. Part 2 describes tissue culture cell lines derived by the insertion of transgenes, including human telomerase reverse transcriptase, SV40 T antigen and human papillomavirus genes. Part 2 also includes xenograft lines that require propagation and passage in vivo in mice. MATERIALS AND METHODS Prostate cell lines included in this review were identified by extensive searching of the literature using several strategies, including PubMed searches and book chapter reviews. RESULTS In total we describe the derivation, phenotype, genotype and characterization of molecular markers expressed by approximately 200 lines and sublines used in PCa research, including ones derived from primary tumors, metastases and normal prostate tissue. We paid particular attention to the expression of prostate specific antigen, androgen receptor, cytokeratins and other molecular markers used to indicate the status of PCa and the prostatic lineage of a given line. In an attempt to provide PCa researchers with a resource of information regarding new and established cell lines we have also created an online database of these PCa cell lines freely accessible via the World Wide Web at http://www.CaPCellLines.com. The web based interface allows researchers to peruse and print information regarding cell lines, add new cell lines and update or add new information regarding established cell lines. CONCLUSIONS This compendium of cell lines currently used in PCa research combined with access to our on-line database provides researchers with a continually updated and valuable resource for investigating the molecular mechanisms of PCa.

[1]  J. Pontes,et al.  Immunochemical identification of prostatic epithelial cells in culture. , 1979, Investigative urology.

[2]  C. Sawyers,et al.  Development of an animal model for prostate cancer cell metastasis to adult human bone. , 2001, Anticancer research.

[3]  D. Williams,et al.  A human prostatic stromal myofibroblast cell line WPMY-1: a model for stromal-epithelial interactions in prostatic neoplasia. , 1999, Carcinogenesis.

[4]  D. Horsfall,et al.  Xenografted small cell undifferentiated cancer of prostate: Possible common origin with prostatic adenocarcinoma , 1988, The Prostate.

[5]  C. Korch,et al.  TSU-Pr1 and JCA-1 cells are derivatives of T24 bladder carcinoma cells and are not of prostatic origin. , 2001, Cancer research.

[6]  L. Chung,et al.  Androgen-repressed phenotype in human prostate cancer. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[7]  G. Jenster,et al.  A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. , 1990, Biochemical and biophysical research communications.

[8]  U. Stenram,et al.  Differential expression of uPA in an aggressive (DU 145) and a nonaggressive (1013L) human prostate cancer xenograft , 1995, The Prostate.

[9]  M. Webber,et al.  Cadmium-induced malignant transformation of human prostate epithelial cells. , 2001, Cancer research.

[10]  M. Stearns,et al.  Isolation and characterization of PC-3 human prostatic tumor sublines which preferentially metastasize to select organs in S.C.I.D. mice. , 1991, Differentiation; research in biological diversity.

[11]  L. Chung,et al.  Stromal-epithelial interactions in sex differentiation. , 1980, Biology of reproduction.

[12]  Ming-Shyue Lee,et al.  ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells , 2003, Oncogene.

[13]  F. Claas,et al.  Expression of HLA-like structures on a permanent human tumor line PC-93. , 2008, Tissue antigens.

[14]  Kaighn Me Human prostatic epithelial cell culture models. , 1980 .

[15]  J. M. Blumberg,et al.  Variations in morphology of urinary bladder epithelium, special reference to cystitis glandularis and carcinomas. , 1952, The Journal of urology.

[16]  R. Kushima,et al.  Establishment and characterization of a prostatic small‐cell carcinoma cell line (PSK‐1) derived from a patient with Klinefelter syndrome , 2000, The Prostate.

[17]  T. Meng,et al.  Tyrosine phosphorylation of a 185 kDa phosphoprotein (pp185) inversely correlates with the cellular activity of human prostatic acid phosphatase. , 1996, Biochemical and biophysical research communications.

[18]  A. Belldegrun,et al.  Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process. , 1999, Cancer research.

[19]  C. Jackson-Cook,et al.  Tumorigenicity of SV40 T antigen immortalized human prostate epithelial cells: Association with decreased epidermal growth factor receptor (EGFR) expression , 1994, International journal of cancer.

[20]  W. Birchmeier,et al.  Hepatocyte growth factor/scatter factor induces a variety of tissue- specific morphogenic programs in epithelial cells , 1995, The Journal of cell biology.

[21]  S. Schwartz,et al.  A new human prostate carcinoma cell line, 22Rv1 , 1999, In Vitro Cellular & Developmental Biology - Animal.

[22]  R. Hubert,et al.  STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. Weijerman,et al.  Expression of prostatic factors measured by reverse transcription polymerase chain reaction in human papillomavirus type 18 deoxyribonucleic acid immortalized prostate cell lines. , 1998, Urology.

[24]  K. Pienta,et al.  Establishment and characterization of a new human prostatic cancer cell line: DuCaP. , 2001, In vivo.

[25]  K. Nakashiro,et al.  Androgen receptor expression in androgen‐independent prostate cancer cell lines , 2001, The Prostate.

[26]  F. Meyers,et al.  Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  R. K. Bright,et al.  Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens. , 1997, Cancer research.

[28]  I. Leav,et al.  Adenocarcinoma of the canine prostate , 1968, Cancer.

[29]  T. Chen,et al.  Chromosome identity of human prostate cancer cell lines, PC-3 and PPC-1. , 1993, Cytogenetics and cell genetics.

[30]  D. Peehl,et al.  Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a. , 1999, The Journal of urology.

[31]  D. Paulson,et al.  Establishment of a long‐term adenocarcinoma of the prostate cell line in the nude mouse , 1985 .

[32]  R. Ostenson,et al.  Human primary prostate tumor cell line, ALVA‐31: A new model for studying the hormonal regulation of prostate tumor cell growth , 1993, The Prostate.

[33]  L. Chung,et al.  LNCaP progression model of human prostate cancer: Androgen‐independence and osseous metastasis , 2000, The Prostate.

[34]  P. Hermanek,et al.  Human prostatic adenocarcinoma: Some characteristics of a serially transplantable line in nude mice (PC 82) , 1980, The Prostate.

[35]  J. Gingrich,et al.  Establishment and characterization of a new human prostatic carcinoma cell line (DuPro-1). , 1991, The Journal of urology.

[36]  S. Hayward,et al.  Malignant transformation in a nontumorigenic human prostatic epithelial cell line. , 2001, Cancer research.

[37]  M. Gleave,et al.  Derivation of androgen‐independent human LNCaP prostatic cancer cell sublines: Role of bone stromal cells , 1994, International journal of cancer.

[38]  M. Fullerton,et al.  Ectopic hormone production by a prostatic small cell carcinoma xenograft line , 1988, Molecular and Cellular Endocrinology.

[39]  I. Kondo,et al.  Establishment of a new prostatic carcinoma cell line (TSU-Pr1). , 1987, The Journal of urology.

[40]  Christopher J. Logothetis,et al.  Model Systems of Prostate Cancer: Uses and Limitations , 1998, Cancer and Metastasis Reviews.

[41]  B. Dutrillaux,et al.  Clinical and experimental progression of a new model of human prostate cancer and therapeutic approach. , 2001, The American journal of pathology.

[42]  E. Wills,et al.  Site‐specific growth of the prostate xenograft line UCRU‐PR‐2 , 1989, The Prostate.

[43]  E. Hoal-van Helden,et al.  Detection by DNA fingerprinting of somatic changes during the establishment of a new prostate cell line. , 1994, British Journal of Cancer.

[44]  A. Belldegrun,et al.  WISH-PC2: a unique xenograft model of human prostatic small cell carcinoma. , 2000, Cancer research.

[45]  K. Pienta,et al.  VCaP, a cell-based model system of human prostate cancer. , 2001, In vivo.

[46]  L. Chung,et al.  Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. , 1994, Cancer research.

[47]  P. Troncoso,et al.  c-met proto-oncogene expression in benign and malignant human prostate tissues. , 1995, The Journal of urology.

[48]  R. Vessella,et al.  Comparative genomic hybridization and molecular cytogenetic characterization of two prostate cancer xenografts , 1997, Genes, chromosomes & cancer.

[49]  A. Pantuck,et al.  CL1-GFP: an androgen independent metastatic tumor model for prostate cancer. , 2000, The Journal of urology.

[50]  Mike Wilson,et al.  Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[51]  S. Naylor,et al.  Retention of chromosome 3 in extrapulmonary small cell cancer shown by molecular and cytogenetic studies. , 1989, Journal of the National Cancer Institute.

[52]  C. Harris,et al.  Transformation of human neonatal prostate epithelial cells by strontium phosphate transfection with a plasmid containing SV40 early region genes. , 1989, Cancer research.

[53]  M. Yamaoka,et al.  Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline. , 2003, Cancer research.

[54]  M. Webber,et al.  Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression , 2001, The Prostate.

[55]  C. Jackson-Cook,et al.  Cytogenetic characterization of the human prostate cancer cell line P69SV40T and its novel tumorigenic sublines M2182 and M15. , 1996, Cancer genetics and cytogenetics.

[56]  N. Maitland,et al.  In Vitro Models to Study Cellular Differentiation and Function in Human Prostate Cancers , 2001, Radiation Research.

[57]  P. Nelson,et al.  A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49. , 2002, The American journal of pathology.

[58]  R L Vessella,et al.  Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[59]  F. Smedts,et al.  Identification of intermediate cell types by keratin expression in the developing human prostate , 1998, The Prostate.

[60]  D. Paulson,et al.  Isolation of a human prostate carcinoma cell line (DU 145) , 1978, International journal of cancer.

[61]  N. Hay,et al.  Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest. , 1998, Molecular endocrinology.

[62]  W. V. van Weerden,et al.  Use of nude mouse xenograft models in prostate cancer research , 2000, The Prostate.

[63]  R. Sellers,et al.  Cultured stromal cells: An in vitro model of prostatic mesenchymal biology , 2000, The Prostate.

[64]  M. Webber,et al.  Malignant transformation of human prostate epithelial cells by N-nitroso-N-methylurea. , 1997, Cancer research.

[65]  W. Isaacs,et al.  Prostate cancer : biology, genetics, and the new therapeutics , 2007 .

[66]  D. Johnston,et al.  Establishment of two human prostate cancer cell lines derived from a single bone metastasis. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[67]  R. Dahiya,et al.  Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1 , 2007, In Vitro Cellular & Developmental Biology - Animal.

[68]  C. Korch,et al.  Molecular characterization of human prostate carcinoma cell lines , 2003, The Prostate.

[69]  C. Harris,et al.  Strontium phosphate transfection of human cells in primary culture: stable expression of the simian virus 40 large-T-antigen gene in primary human bronchial epithelial cells , 1987, Molecular and cellular biology.

[70]  B. Dave,et al.  Decreased androgen-responsive growth of human prostate cancer is associated with increased genetic alterations. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[71]  W. Rosner,et al.  Characterization of ALVA-41 cells, a new human prostatic cancer cell line , 1994, Steroids.

[72]  G. Cunha,et al.  Glandular epithelial induction by embryonic mesenchyme in adult bladder epithelium of BALB/c mice. , 1980, Investigative urology.

[73]  T. H. van der Kwast,et al.  Development of seven new human prostate tumor xenograft models and their histopathological characterization. , 1996, The American journal of pathology.

[74]  K. M. Roberson,et al.  Isolation and characterization of a novel human prostatic stromal cell culture: DuK50 , 1995, In Vitro Cellular & Developmental Biology - Animal.

[75]  D. Peehl,et al.  Erratum: Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor (Nature Medicine (2000) 6 (703-706)) , 2000 .

[76]  R. Nagle,et al.  N-Cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion withStromal cells. , 1999, The American journal of pathology.

[77]  C. Korch,et al.  Widely used prostate carcinoma cell lines share common origins , 2001, The Prostate.

[78]  K. Nakashiro,et al.  Hepatocyte growth factor secreted by prostate-derived stromal cells stimulates growth of androgen-independent human prostatic carcinoma cells. , 2000, The American journal of pathology.

[79]  M. Mally,et al.  Cell characterization by use of multiple genetic markers. , 1984, Advances in experimental medicine and biology.

[80]  M. Resnick,et al.  Xenografts of primary human prostatic carcinoma. , 1993, Journal of the National Cancer Institute.

[81]  T. Tammela,et al.  Human pHyde is not a classical tumor suppressor gene in prostate cancer , 2003, International journal of cancer.

[82]  L. Terracio,et al.  Oncogenicity of rat prostate cells transformed in vitro with cadmium chloride , 1988, Archives of Toxicology.

[83]  H. Klocker,et al.  DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction , 1993, The Prostate.

[84]  S. Schwartz,et al.  CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. , 1996, Cancer research.

[85]  George L. Wright,et al.  Phenotypic and cytogenetic characterization of a cell line derived from primary prostatic carcinoma , 1989, International journal of cancer.

[86]  J. Rhim,et al.  Loss of response to epidermal growth factor and retinoic acid accompanies the transformation of human prostatic epithelial cells to tumorigenicity with v-Ki-ras. , 1997, Carcinogenesis.

[87]  M. Webber,et al.  Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. , 1997, Carcinogenesis.

[88]  D. Williams,et al.  Prostate specific antigen and androgen receptor induction and characterization of an immortalized adult human prostatic epithelial cell line. , 1996, Carcinogenesis.

[89]  G. Murphy,et al.  LNCaP model of human prostatic carcinoma. , 1983, Cancer research.

[90]  P. Hein,et al.  Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium , 2000, Breast Cancer Research.

[91]  C. Tepper,et al.  Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line. , 2002, Cancer research.

[92]  P. Ye,et al.  Androgen receptor up-regulates insulin-like growth factor binding protein-5 (IGFBP-5) expression in a human prostate cancer xenograft. , 1999, Endocrinology.

[93]  L. Ossowski,et al.  Activation of Rb and decline in androgen receptor protein precede retinoic acid–induced apoptosis in androgen‐dependent LNCaP cells and their androgen‐independent derivative , 1999, Journal of cellular physiology.

[94]  P. Hermanek,et al.  Prostatic adenocarcinoma PC EW, a new human tumor line transplantable in nude mice , 1984, The Prostate.

[95]  E. Kruse,et al.  Identification by C‐banding of two human prostate tumour cell lines, 1013L and DU 145 , 1989, International journal of cancer.

[96]  H. Grossman,et al.  UM-SCP-1, a new human cell line derived from a prostatic squamous cell carcinoma. , 1984, Cancer research.

[97]  G. Miller,et al.  Karyotypic similarity identified by multiplex‐FISH relates four prostate adenocarcinoma cell lines: PC‐3, PPC‐1, ALVA‐31, and ALVA‐41 , 2001, Genes, chromosomes & cancer.

[98]  M. Lucia,et al.  Spectral karyotype (SKY) analysis of human prostate carcinoma cell lines , 2003, The Prostate.

[99]  J. Pontes,et al.  MA 160 and EB 33 cell lines: HeLa cell contaminants, hybrids or prostatic epithelial cells? , 1979, In Vitro.

[100]  J. McNeal,et al.  Differential cytokeratin expression in normal, hyperplastic and malignant epithelial cells from human prostate. , 1990, The Journal of urology.

[101]  P. Weijerman,et al.  Characterization of adult human prostatic epithelial-cells immortalized by polybrene-induced DNA transfection with a plasmid containing an origin-defective sv40-genome. , 1994, International journal of oncology.

[102]  A. Cress,et al.  PEAZ‐1: A new human prostate neoplastic epithelial cell line , 2001, The Prostate.

[103]  F. Schröder,et al.  Human prostatic carcinoma in cell culture: Preliminary report on the development and characterization of an epithelial cell line (EB 33) , 1974, Urological Research.

[104]  A. Vannier,et al.  IPM‐FISH, a new M‐FISH approach using IRS‐PCR painting probes: Application to the analysis of seven human prostate cell lines , 2001, Genes, chromosomes & cancer.

[105]  J. Rhim In vitro human cell culture models for the study of prostate cancer , 2000, Prostate Cancer and Prostatic Diseases.

[106]  S. Schwartz,et al.  CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma. , 1994, Cancer research.

[107]  L. Liotta,et al.  Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. , 1995, Cancer research.

[108]  K. Münger,et al.  Stabilization and functional impairment of the tumor suppressor p53 by the human papillomavirus type 16 E7 oncoprotein. , 2002, Virology.

[109]  R. Dahiya,et al.  Establishment and characterization of a human primary prostatic adenocarcinoma cell line (ND-1). , 1992, The Journal of urology.

[110]  G. Bepler,et al.  Establishment and identification of small cell lung cancer cell lines having classic and variant features. , 1985, Cancer research.

[111]  K. A. Klein,et al.  Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice , 1997, Nature Medicine.

[112]  Desok Kim,et al.  Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes. , 1998, Cancer research.

[113]  D. Lubaroff HPC-36: an epithelial tissue culture line derived from human prostate adenocarcinoma. , 1978, National Cancer Institute monograph.

[114]  Donna M. Peehl,et al.  Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor , 2000, Nature Medicine.

[115]  M. Webber,et al.  Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications part I. Cell markers and immortalized nontumorigenic cell lines , 1996, The Prostate.

[116]  S. Naito,et al.  Antiproliferative Effect of Calcitriol on Human Prostatic Cancer Cell Lines: Unrelated to the Expression of Major Histocompatibility Complex Antigens or Intercellular Adhesion Molecule‐1 (ICAM‐1) , 1998, International journal of urology : official journal of the Japanese Urological Association.

[117]  F. Bladou,et al.  A Nod Scid mouse model to study human prostate cancer , 2002, Prostate Cancer and Prostatic Diseases.

[118]  P. Weijerman,et al.  Lipofection-mediated immortalization of human prostatic epithelial cells of normal and malignant origin using human papillomavirus type 18 DNA. , 1994, Cancer research.

[119]  C. Sawyers,et al.  Xenograft Models and the Molecular Biology of Human Prostate Cancer , 2001 .

[120]  T. McDonnell,et al.  TabBO: a model reflecting common molecular features of androgen-independent prostate cancer. , 2000, Clinical Cancer Research.

[121]  I. Fidler,et al.  Metastatic behavior of human tumor cell lines grown in the nude mouse. , 1984, Cancer research.

[122]  J. Rhim,et al.  Neoplastic transformation of a human prostate epithelial cell line by the v‐Ki‐ras oncogene , 1993, The Prostate.

[123]  J. Lechner,et al.  Establishment and characterization of a human prostatic carcinoma cell line (PC-3). , 1979, Investigative urology.

[124]  C. Larsson,et al.  5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell lines , 2001, Genes, chromosomes & cancer.

[125]  R. Ostenson,et al.  Effects of sex hormone binding globulin (SHBG) on human prostatic carcinoma , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[126]  D. Paulson,et al.  Spontaneous metastasis of cells of the human prostate carcinoma cell line PC-3 in athymic nude mice. , 1982, The Journal of urology.

[127]  O. Cussenot,et al.  Immortalization of human adult normal prostatic epithelial cells by liposomes containing large T-SV40 gene. , 1991, The Journal of urology.

[128]  F. Kaye,et al.  Molecular genetic characterization of neuroendocrine lung cancer cell lines. , 1995, Anticancer research.

[129]  J. Rhim,et al.  A novel human cancer culture model for the study of prostate cancer , 2001, Oncogene.

[130]  J A Thomson,et al.  Short tandem repeat profiling provides an international reference standard for human cell lines , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[131]  M. Webber,et al.  Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications. Part 3. Oncogenes, suppressor genes, and applications , 1997, The Prostate.

[132]  S. Hayward,et al.  Cell differentiation lineage in the prostate. , 2001, Differentiation; research in biological diversity.

[133]  C. Kao,et al.  Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate‐specific antigen‐producing tumors in athymic and SCID/bg mice using LNCaP and lineage‐derived metastatic sublines , 1998, International journal of cancer.

[134]  H. Drexler,et al.  Widespread intraspecies cross‐contamination of human tumor cell lines arising at source , 1999, International journal of cancer.

[135]  W. Isaacs,et al.  DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. , 1999, Cancer research.

[136]  J. Addonizio,et al.  Establishment of new human prostatic cancer cell line (JCA-1). , 1990, Urology.

[137]  A. Brothman,et al.  Metastatic properties of the human prostatic cell line, PPC-1, in athymic nude mice. , 1991, The Journal of urology.

[138]  S. Maygarden,et al.  Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line , 1998, The Prostate.

[139]  D. Eisenberg,et al.  Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone‐refractory prostate cancer tumor system , 2003, The Prostate.

[140]  M. Webber,et al.  Stepwise immortalization and transformation of adult human prostate epithelial cells by a combination of HPV-18 and v-Ki-ras. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[141]  Martin R. Schneider,et al.  Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system , 1999, British Journal of Cancer.

[142]  J. Lechner,et al.  Differential properties among clones of simian virus 40-transformed human epithelial cells. , 1980, Carcinogenesis.

[143]  N. Goldstein,et al.  Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[144]  N. D. Reed Proceedings of the third International Workshop on Nude Mice , 1982 .

[145]  S. Arya,et al.  The LNCaP cell line--a new model for studies on human prostatic carcinoma. , 1980, Progress in clinical and biological research.

[146]  D. Paulson,et al.  Characterization of a human prostate adenocarcinoma cell line (DU 145) as a monolayer culture and as a solid tumor in athymic mice. , 1980, Progress in clinical and biological research.

[147]  R. Vollmer,et al.  Heterotransplantation of a human prostatic adenocarcinoma cell line in nude mice. , 1977, Cancer research.

[148]  G. Wilding,et al.  Efficacy of suramin against human prostate carcinoma DU145 xenografts in nude mice , 1999, Cancer Chemotherapy and Pharmacology.

[149]  M. Tsai,et al.  Molecular Mechanisms of Androgen-Independent Growth of Human Prostate Cancer LNCaP-AI Cells1. , 1999, Endocrinology.

[150]  P. Russell,et al.  Characterization of a human, sex steroid-responsive transitional cell carcinoma maintained as a tumor line (R198) in athymic nude mice. , 1984, Cancer research.

[151]  Williams Rd Human urologic cancer cell lines. , 1980 .

[152]  T. H. van der Kwast,et al.  Androgen‐independent growth is induced by neuropeptides in human prostate cancer cell lines , 2000, The Prostate.

[153]  R. Vessella,et al.  LuCaP 35: A new model of prostate cancer progression to androgen independence , 2003, The Prostate.

[154]  L. Liotta,et al.  Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. , 1996, Cancer research.

[155]  M. Webber,et al.  Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications part 2. Tumorigenic cell lines , 1997, The Prostate.

[156]  J. Thrasher,et al.  The effect on the insulin-like growth factor system in human prostate epithelial cells of immortalization and transformation by simian virus-40 T antigen. , 1996, The Journal of clinical endocrinology and metabolism.